VivoSim Labs, Inc. Unrealized Gain (Loss) on Derivatives
VivoSim Labs, Inc. (VIVS) reported Unrealized Gain (Loss) on Derivatives of -$27.37 million for the 80-month period ending 2013-12-31, per its 10-Q filed 2014-02-06.
Discontinued › Cash Flow › Operating Activities
us-gaap:UnrealizedGainLossOnDerivatives · last filed 2014-02-06
- VivoSim Labs, Inc. unrealized gain (loss) on derivatives for the quarter ending 2013-12-31 was -$586.00K.
- VivoSim Labs, Inc. unrealized gain (loss) on derivatives for the quarter ending 2013-09-30 was -$4.79M, a 111.33% decline year-over-year.
- VivoSim Labs, Inc. unrealized gain (loss) on derivatives for the quarter ending 2013-06-30 was -$23.00K.
- VivoSim Labs, Inc. unrealized gain (loss) on derivatives for the quarter ending 2013-03-31 was -$12.03M.
- VivoSim Labs, Inc. unrealized gain (loss) on derivatives for fiscal 2012 was -$9.93M.
- VivoSim Labs, Inc. unrealized gain (loss) on derivatives for fiscal 2011 was -$7.00K.
| Period end | Unrealized Gain (Loss) on Derivatives 3 month | Unrealized Gain (Loss) on Derivatives 3 month as first filed | Unrealized Gain (Loss) on Derivatives 6 month | Unrealized Gain (Loss) on Derivatives 9 month | Unrealized Gain (Loss) on Derivatives 12 month | Unrealized Gain (Loss) on Derivatives 59 month | Unrealized Gain (Loss) on Derivatives 62 month | Unrealized Gain (Loss) on Derivatives 65 month | Unrealized Gain (Loss) on Derivatives 68 month | Unrealized Gain (Loss) on Derivatives 71 month | Unrealized Gain (Loss) on Derivatives 74 month | Unrealized Gain (Loss) on Derivatives 77 month | Unrealized Gain (Loss) on Derivatives 80 month |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2013-12-31 | -$586.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2014-02-06 | -$5.37M derived: sum of 2 quarters · filed 2014-02-06 | -$5.40M 10-Q · filed 2014-02-06 | -$17.43M derived: sum of 4 quarters · filed 2014-02-06 | -$27.37M 10-Q · filed 2014-02-06 | ||||||||
| 2013-09-30 | -$4.79M derived: 10-Q 6 month − 10-Q 3 month · filed 2013-11-08 | -$4.81M 10-Q · filed 2013-11-08 | -$16.84M derived: sum of 3 quarters · filed 2013-11-08 | -$21.59M derived: sum of 4 quarters · filed 2014-02-06 | -$26.78M 10-Q · filed 2013-11-08 | ||||||||
| 2013-06-30 | -$23.00K 10-Q · filed 2013-08-09 | -$12.06M derived: sum of 2 quarters · filed 2013-08-09 | -$16.80M derived: sum of 3 quarters · filed 2014-02-06 | $25.45M derived: sum of 4 quarters · filed 2014-02-06 | -$22.00M 10-Q · filed 2013-08-09 | ||||||||
| 2013-03-31 | -$12.03M 10-KT · filed 2013-05-24 | -$16.77M derived: sum of 2 quarters · filed 2014-02-06 | $25.48M derived: sum of 3 quarters · filed 2014-02-06 | -$8.46M derived: sum of 4 quarters · filed 2014-02-06 | -$21.97M 10-KT · filed 2013-05-24 | ||||||||
| 2012-12-31 | -$4.74M derived: 10-Q 9 month − 10-Q 6 month · filed 2014-02-06 | $37.51M derived: sum of 2 quarters · filed 2014-02-06 | $3.58M 10-Q · filed 2014-02-06 | -$9.93M 10-KT · filed 2013-05-24 | -$9.94M 10-K · filed 2013-03-15 | ||||||||
| 2012-09-30 | $42.25M derived: 10-Q 6 month − 10-Q 3 month · filed 2013-11-08 | $8.31M 10-Q · filed 2013-11-08 | -$5.19M 10-Q · filed 2012-11-14 | -$5.20M 10-Q · filed 2012-11-14 | |||||||||
| 2012-06-30 | -$33.94M 10-Q · filed 2013-08-09 | -$47.44M 10-Q · filed 2012-08-14 | -$47.45M 10-Q · filed 2012-08-14 | ||||||||||
| 2012-03-31 | -$13.51M 10-KT · filed 2013-05-24 | -$13.51M 10-Q · filed 2012-05-15 | -$13.51M 10-Q · filed 2012-05-15 | ||||||||||
| 2011-12-31 | -$7.00K 10-KT · filed 2013-05-24 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| WINDTREE THERAPEUTICS INC /DE/ (WINT) | United States | $0.003B | -0.32 |
| Calidi Biotherapeutics, Inc. (CLDI) | United States | $0.003B | |
| CURIS INC (CRIS) | United States | $0.002B | -0.05 |
| PharmaCyte Biotech, Inc. (PMCB) | United States | $0.005B | |
| Silexion Therapeutics Corp (SLXN) | $0.001B | ||
| AIM ImmunoTech Inc. (AIM) | United States | $0.006B | |
| CREATIVE MEDICAL TECHNOLOGY HOLDINGS, INC. (CELZ) | United States | $0.006B | |
| CERO THERAPEUTICS HOLDINGS, INC. (CERO) | United States | $0.007B | |
| TScan Therapeutics, Inc. (TCRX) | United States | $0.008B | -1.23 |
| Senti Biosciences Holdings, Inc. (SNTI) | United States | $0.011B | -0.70 |